Abstract
We present a patient with generalized younger primarily undifferentiated papillary thyroid cancer, which has been sorafenib therapy achieved disease stabilization for a period of 7 months.
We present a patient with generalized younger primarily undifferentiated papillary thyroid cancer, which has been sorafenib therapy achieved disease stabilization for a period of 7 months.